Form F-10 - Registration Statement for Securities of certain Canadian Issuers.:
SEC Accession No. 0001104659-20-070925
Filing Date
2020-06-08
Accepted
2020-06-08 17:24:54
Documents
5

Document Format Files

Seq Description Document Type Size
1 F-10 tm2021919d1_f10.htm F-10 225434
2 EXHIBIT 5.1 tm2021919d1_ex5-1.htm EX-5.1 5512
3 GRAPHIC image_001.jpg GRAPHIC 4565
4 GRAPHIC image_002.jpg GRAPHIC 4167
5 GRAPHIC eylogo.jpg GRAPHIC 2834
  Complete submission text file 0001104659-20-070925.txt   248265
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10 | Act: 33 | File No.: 333-239025 | Film No.: 20950076
SIC: 2834 Pharmaceutical Preparations